Fahad. Zadjali, et.al., SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, 26

http://rdf.ncbi.nlm.nih.gov/pubmed/22562833

Fahad. Zadjali, et.al., SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice., FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, 26

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased susceptibility to hepatic steatosis_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0002310IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• insulin resistance_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005331IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased tumor necrosis factor secretion_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0008560IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• abnormal circulating cytokine level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0010210IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• decreased circulating insulin-like growth factor I level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0004701IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased triglyceride level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005317IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased circulating insulin level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0002079IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased circulating interferon-gamma level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0008577IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased renal fat pad weight_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0009302IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• decreased circulating growth hormone level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005120IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• liver inflammation_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0001860IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• decreased liver triglyceride level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0009356IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased interleukin-1 beta secretion_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0008657IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased interferon-gamma secretion_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0008566IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased circulating glucose level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005559IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• increased circulating interleukin-1 beta level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0008641IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• abnormal circulating hormone level_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005418IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• abnormal glucose homeostasis_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0002078IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• impaired glucose tolerance_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0005293IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi
• abnormal macrophage physiology_Socs2<tm1Wehi>/Socs2<tm1Wehi>
  http://metadb.riken.jp/0002451IC57BL6C57BL6JSocs2tm1WehiSocs2tm1WehiSocs2tm1Wehi